Segment Information

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment Information

Note 15 – Segment Information

The Company has identified two operating segments, diagnostic services and consumer products, based on the manner in which the Company’s CEO as CODM assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. The unallocated corporate expenses mainly included professional fees associated with the public company.

The following table is a summary of segment information for Fiscal 2021 and Fiscal 2020 (in thousands):

	For the years ended
	December 31, 2021			December 31, 2020
Net revenues
Diagnostic services	$	68,559		$	1,277
Consumer products		10,483			13,237
Consolidated net revenue		79,042			14,514
Cost of revenue
Diagnostic services		29,415			644
Consumer products		7,639			9,264
Consolidated cost of revenue		37,054			9,908
Depreciation and amortization expense
Diagnostic services		1,976			37
Consumer products		7			89
Total Depreciation and amortization expense		1,983			126
Operating and other expenses		34,700			6,818
Income (loss) from continuing operations, before income taxes
Diagnostic services		18,197			(270	)
Consumer products		(1,714	)		1,962
Unallocated corporate		(11,178	)		(4,006	)
Total income (loss) from continuing operations, before income taxes		5,305			(2,314	)
Income tax benefit (expense)		968			(12	)
Total income (loss) from continuing operations, after income taxes		6,273			(2,326	)
Income from discontinued operations, before income taxes		-			201
Net income (loss)	$	6,273		$	(2,125	)

The following table is a summary of segment information for Fiscal 2021 and Fiscal 2020 (in thousands):

	December 31,		December 31,
	2021		2020
ASSETS
Diagnostic services	$	51,150	$	13,410
Consumer products		24,139		6,261
Unallocated corporate		14,006		11,734
Total assets	$	89,295	$	31,405